Lowered aortic impedance as therapy for severe mitral regurgitation.
D000328:Adult; D001011:Aorta; D001794:Blood Pressure; D006328:Cardiac Catheterization; D002302:Cardiac Output / Q000187:drug effects; D005292:Ferricyanides / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D006339:Heart Rate; D006350:Heart Valve Prosthesis; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008944:Mitral Valve Insufficiency / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D009569:Nitric Oxide / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D011182:Postoperative Care; D011651:Pulmonary Artery; D011674:Pulse; D014655:Vascular Resistance / Q000187:drug effects*; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use
D005292:Ferricyanides; D014665:Vasodilator Agents; D009569:Nitric Oxide